Yang NN - Search Results

1

Evaluation of the major metabolites of raloxifene as modulators of tissue selectivity.

Dodge JA, Lugar CW, Cho S, Short LL, Sato M, Yang NN, Spangle LA, Martin MJ, Phillips DL, Glasebrook AL, Osborne JJ, Frolik CA, Bryant HU. Dodge JA, et al. Among authors: yang nn. J Steroid Biochem Mol Biol. 1997 Apr;61(1-2):97-106. doi: 10.1016/s0960-0760(97)00008-3. J Steroid Biochem Mol Biol. 1997. PMID: 9328215

2

Estrogen and raloxifene stimulate transforming growth factor-beta 3 gene expression in rat bone: a potential mechanism for estrogen- or raloxifene-mediated bone maintenance.

Yang NN, Bryant HU, Hardikar S, Sato M, Galvin RJ, Glasebrook AL, Termine JD. Yang NN, et al. Endocrinology. 1996 May;137(5):2075-84. doi: 10.1210/endo.137.5.8612550. Endocrinology. 1996. PMID: 8612550

3

Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene.

Yang NN, Venugopalan M, Hardikar S, Glasebrook A. Yang NN, et al. Science. 1996 Aug 30;273(5279):1222-5. doi: 10.1126/science.273.5279.1222. Science. 1996. PMID: 8703055

4

Molecular determinants of tissue selectivity in estrogen receptor modulators.

Grese TA, Sluka JP, Bryant HU, Cullinan GJ, Glasebrook AL, Jones CD, Matsumoto K, Palkowitz AD, Sato M, Termine JD, Winter MA, Yang NN, Dodge JA. Grese TA, et al. Among authors: yang nn. Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):14105-10. doi: 10.1073/pnas.94.25.14105. Proc Natl Acad Sci U S A. 1997. PMID: 9391160 Free PMC article.

5

Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators.

Grese TA, Pennington LD, Sluka JP, Adrian MD, Cole HW, Fuson TR, Magee DE, Phillips DL, Rowley ER, Shetler PK, Short LL, Venugopalan M, Yang NN, Sato M, Glasebrook AL, Bryant HU. Grese TA, et al. Among authors: yang nn. J Med Chem. 1998 Apr 9;41(8):1272-83. doi: 10.1021/jm970688z. J Med Chem. 1998. PMID: 9548817

6

An estrogen receptor basis for raloxifene action in bone.

Bryant HU, Glasebrook AL, Yang NN, Sato M. Bryant HU, et al. Among authors: yang nn. J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):37-44. doi: 10.1016/s0960-0760(98)00147-2. J Steroid Biochem Mol Biol. 1999. PMID: 10418979 Review.

7

Activation of the human estrogen receptor by estrogenic and antiestrogenic compounds in Saccharomyces cerevisiae: a positive selection system.

Shiau SP, Glasebrook A, Hardikar SD, Yang NN, Hershberger CL. Shiau SP, et al. Among authors: yang nn. Gene. 1996 Nov 14;179(2):205-10. doi: 10.1016/s0378-1119(96)00345-9. Gene. 1996. PMID: 8972901

8

Correction: raloxifene response needs more than an element.

Yang NN, Venugopalan M, Hardikar S, Glasebrook A. Yang NN, et al. Science. 1997 Feb 28;275(5304):1249. doi: 10.1126/science.275.5304.1245f. Science. 1997. PMID: 9064777 No abstract available.

9

Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism.

Krishnan V, Ma YL, Chen CZ, Thorne N, Bullock H, Tawa G, Javella-Cauley C, Chu S, Li W, Kohn W, Adrian MD, Benson C, Liu L, Sato M, Zheng W, Pilon AM, Yang NN, Bryant HU. Krishnan V, et al. Among authors: yang nn. Br J Pharmacol. 2018 Jan;175(2):262-271. doi: 10.1111/bph.14028. Epub 2017 Nov 28. Br J Pharmacol. 2018. PMID: 28898923 Free PMC article.

10

C75 [4-methylene-2-octyl-5-oxo-tetrahydro-furan-3-carboxylic acid] activates carnitine palmitoyltransferase-1 in isolated mitochondria and intact cells without displacement of bound malonyl CoA.

Yang N, Kays JS, Skillman TR, Burris L, Seng TW, Hammond C. Yang N, et al. J Pharmacol Exp Ther. 2005 Jan;312(1):127-33. doi: 10.1124/jpet.104.074104. Epub 2004 Sep 8. J Pharmacol Exp Ther. 2005. PMID: 15356215

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page